ImmunoPrecise Antibodies is a biotherapeutic research company in Austin, Texas, founded in 1983. The company specializes in drug discovery and development, utilizing artificial intelligence (AI) and advanced laboratory technologies to accelerate and improve the process of discovering and creating therapeutic antibodies. ImmunoPrecise Antibodies offers various products and services.
ImmunoPrecise Antibodies helps pharmaceutical and biotech companies discover and develop antibodies through lab-based, computational, and animal-based approaches. Its services include target identification and preparation for antibody development, antibody discovery and analysis with desired characteristics, and assessment of their suitability for further development. The company offers protein production services and provides custom manufacturing through its rPEx production platform. It has produced more than 7,500 batches with a purity rate of 90 to 95 percent.
The company offers clients an extensive catalog of protein products through its online store. It is a leading global supplier of organoid growth factors and the exclusive producer of the WNT Surrogate‑Fc fusion protein. It also provides AI-powered drug discovery software that pharmaceutical companies and researchers can use for data analysis, identifying new drug candidates, and gaining insights. It is currently developing a subscription-based software system (SaaS platform) that will help clients manage their data, run analytics, and enhance the efficiency of drug discovery.
There are four key areas where ImmunoPrecise Antibodies applies its antibody discovery/development expertise: therapeutics, companion tools, diagnostics, and protein manufacturing. These areas cover everything from drug-targeting antibodies and supporting reagents like IHC, surrogates, and validation tools, to diagnostic antibodies and custom-produced proteins for research and pre-clinical use.